Status:
RECRUITING
Liposomal Bupivacaine Versus Lidocaine for Skin Graft Donor Site Pain
Lead Sponsor:
University of Kansas Medical Center
Conditions:
Pain, Postoperative
Burns
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Donor site pain study comparing post-operative donor site pain and opioid consumption after use of Lidocaine, Liposomal Bupivicaine or regional nerve block for split thickness skin graft harvesting in...
Detailed Description
The first phase of the study was a randomized controlled study. In the second phase, all subjects will receive fascia iliaca, lateral femoral cutaneous, or femoral nerve blocks based on the proposed d...
Eligibility Criteria
Inclusion
- Spanish/English speaking
- \<20%TBSA; \<5% TBSA deep partial or full thickness burns
Exclusion
- chronic pain syndrome
- \> 20% TBSA burn injury; \> 5% TBSA deep partial or full thickness burn
- pregnant
- allergy to lidocaine or other local anesthetics
- burns to anterior thighs
Key Trial Info
Start Date :
March 18 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT03854344
Start Date
March 18 2019
End Date
December 31 2025
Last Update
April 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Kansas Health System
Kansas City, Kansas, United States, 66160